HIF-dependent antitumorigenic effect of antioxidants in vivo

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Antioxidants are believed to prevent cancer by protecting DNA from reactive oxygen species (ROS) and genomic instability.
• The precise mechanisms underlying the antitumorigenic effects of antioxidants are still under investigation.

Purpose of the Study:

• To investigate the antitumorigenic mechanisms of antioxidants beyond their ROS-scavenging activity.
• To explore the role of hypoxia-inducible factor (HIF) in antioxidant-mediated cancer inhibition.

Main Methods:

• Tested the in vivo efficacy of antioxidants in three distinct tumorigenic models.
• Investigated the association between antioxidant treatment, genomic instability, and HIF-1 levels in a MYC-dependent B lymphoma model.
• Utilized ectopic expression of a stabilized HIF-1 mutant to assess its impact on antioxidant efficacy.

Main Results:

• Antioxidants demonstrated significant antitumorigenic activity across all three tested models.
• Inhibition of B lymphoma xenografts by antioxidants was not linked to reduced genomic instability.
• Antioxidant treatment led to diminished hypoxia-inducible factor (HIF)-1 levels in a manner dependent on prolyl hydroxylase 2 and von Hippel-Lindau protein.
• Restoring HIF-1 levels via a stabilized mutant rescued lymphoma xenografts from antioxidant-induced inhibition.

Conclusions:

• The study challenges the established paradigm that antioxidants primarily exert antitumorigenic effects by reducing DNA damage.
• Diminishing hypoxia-inducible factor (HIF) levels represents a key mechanism through which antioxidants inhibit tumorigenesis.
• These findings highlight a novel therapeutic avenue involving HIF modulation for cancer treatment.